Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes

Metabolomics : Official Journal of the Metabolomic Society
Henk den OudenJoline W Beulens

Abstract

We aimed to identify metabolites to predict patients' response to glucose lowering treatment during the first 5 years after detection of type 2 diabetes. Metabolites were measured by GC-MS in baseline samples from 346 screen-detected type 2 diabetes patients in the ADDITION-NL study. The response to treatment with metformin and/or sulphonylurea (SU) was analysed to identify metabolites predictive of 5 year HbA1c change by multiple regression analysis. Baseline glucose and 1,5 anhydro-glucitol were associated with HbA1c decrease in all medication groups. In patients on SU no other metabolite was associated with HbA1c decrease. A larger set of metabolites was associated with HbA1c change in the metformin and the combination therapy (metformin + SU) groups. These metabolites included metabolites related to liver metabolism, such as 2-hydroxybutanoic acid, 3-hydroxybutanoic acid, 2-hydroxypiperidine and 4-oxoproline). Metabolites involved in oxidative stress and insulin resistance were higher when the HbA1c decrease was larger in the metformin/sulphonylurea group. The associations between baseline metabolites and responsiveness to medication are in line with its mode of action. If these results could be replicated in other populati...Continue Reading

References

Aug 24, 1999·Annals of Internal Medicine·R A DeFronzo
Mar 29, 2000·The Journal of Nutrition·J T Brosnan
Jul 3, 2002·Annals of Internal Medicine·Dmitri KirpichnikovJames R Sowers
Feb 28, 2004·The Journal of Nutrition·Guoyao WuNancy D Turner
Aug 28, 2004·European Journal of Epidemiology·Alex N GoudswaardGuy E H M Rutten
Jan 18, 2006·Analytical Chemistry·Sabina BijlsmaAge K Smilde
Mar 22, 2007·Journal of Proteome Research·J van der GreefR N McBurney
May 2, 2008·Pharmacoepidemiology and Drug Safety·M J KnolA C G Egberts
May 20, 2008·Expert Opinion on Drug Metabolism & Toxicology·Michael A PacanowskiChristina L Aquilante
Sep 23, 2008·The Journal of Nutrition·Robert F Bertolo, Douglas G Burrin
Dec 25, 2008·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Paul Gh JanssenGuy Ehm Rutten
Jul 25, 2009·The American Journal of Clinical Nutrition·Margaret E Brosnan, John T Brosnan
Oct 31, 2009·Diabetes·James R BainChristopher B Newgard
Mar 13, 2010·Expert Review of Cardiovascular Therapy·Christina L Aquilante
Jul 23, 2011·Free Radical Biology & Medicine·Sergey Dikalov
Sep 22, 2011·The Australian Journal of Rural Health·Nicole J KellowHanan Khalil
Nov 24, 2011·Molecular and Cellular Endocrinology·Marc Prentki, S R Murthy Madiraju
Jan 4, 2012·Annals of the New York Academy of Sciences·Emily Jane Gallagher, Derek LeRoith
Jan 6, 2012·Acta Diabetologica·Alberto M DavalliFranco B Folli
Feb 11, 2012·Journal of the American College of Cardiology·Scott M Grundy
Mar 20, 2012·Translational Research : the Journal of Laboratory and Clinical Medicine·Timothy J Lyons, Arpita Basu
May 23, 2012·Vascular Pharmacology·Cristiano Capurso, Antonio Capurso
Feb 5, 2013·Frontiers of Medicine·Jingyi LuWei Jia

❮ Previous
Next ❯

Citations

Jul 14, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bingbing LiHoukai Li
Apr 11, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·N SafaiUNKNOWN CIMT Trial Group
Aug 17, 2018·The Journal of Clinical Endocrinology and Metabolism·Leen M 't HartMarleen M J van Greevenbroek
Oct 5, 2019·Diabetes·Zsu-Zsu ChenUNKNOWN Diabetes Prevention Program Research Group
May 20, 2020·Metabolites·Egon Taalberg, Kalle Kilk
Aug 29, 2019·Drug Metabolism Reviews·Adriana FodorGabriela Roman
Sep 1, 2016·Personalized Medicine·Adriana Fodor, Eddy Karnieli
Jul 4, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jeong-Eun ParkKwang-Hee Shin
Feb 19, 2021·Molecular Omics·Balasubramanian Chellammal MuthubharathiKrishnaswamy Balamurugan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.